Page last updated: 2024-11-12

(1-((1-methylpiperidin-2-yl)methyl)-1h-indol-3-yl)(naphthalen-1-yl)methanone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

(1-((1-methylpiperidin-2-yl)methyl)-1H-indol-3-yl)(naphthalen-1-yl)methanone: a cannabinergic agent; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID9929889
CHEMBL ID68641
SCHEMBL ID9302415
MeSH IDM0575615

Synonyms (25)

Synonym
CHEMBL68641 ,
bdbm50172553
[1-(1-methyl-piperidin-2-ylmethyl)-1h-indol-3-yl]-naphthalen-1-yl-methanone
am 1220
AKOS015999838
methanone, [1-[(1-methyl-2-piperidinyl)methyl]-1h-indol-3-yl]-1-naphthalenyl-
am-1220
137642-54-7
AM1220 ,
(1-((1-methylpiperidin-2-yl)methyl)-1h-indol-3-yl)(naphthalen-1-yl)methanone
SCHEMBL9302415
URKVBEKZCMUTQC-UHFFFAOYSA-N ,
{1-[(1-methylpiperidin-2-yl)methyl]-1h-indol-3-yl}(naphthalen-1-yl)methanone
DTXSID50433001
1-(((1-methylpiperidine-2-yl)methyl)indol-3-yl)-naphtalene-1-ylmethanone
am-1220, (+/-)-
methanone, (1-((1-methyl-2-piperidinyl)methyl)-1h-indol-3-yl)-1-naphthalenyl-
(1-((1-methyl-2-piperidinyl)methyl)-1h-indol-3-yl)-1-naphthalenylmethanone
unii-05850m72p2
05850m72p2 ,
BCP21285
am-1220/am1220
3-(1-naphthoyl)-1-(n-methylpiperidin-2-ylmethyl)indole
Q4652479
[1-[(1-methylpiperidin-2-yl)methyl]indol-3-yl]-naphthalen-1-ylmethanone
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Cannabinoid receptor 1Rattus norvegicus (Norway rat)Ki252,859.33390.00020.566510.0000AID254378; AID254448; AID49676
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (7)

Assay IDTitleYearJournalArticle
AID253889Lipophilicity by using ACD/LogD Suite software2005Journal of medicinal chemistry, Sep-08, Volume: 48, Issue:18
Synthesis and structure-activity relationship of a novel series of aminoalkylindoles with potential for imaging the neuronal cannabinoid receptor by positron emission tomography.
AID254448In vitro binding affinity against rat cannabinoid receptor 1 using 0.5 nM [3H]CP-559402005Journal of medicinal chemistry, Sep-08, Volume: 48, Issue:18
Synthesis and structure-activity relationship of a novel series of aminoalkylindoles with potential for imaging the neuronal cannabinoid receptor by positron emission tomography.
AID49675Binding affinity at cannabinoid receptor 1 using rat brain membranes2001Journal of medicinal chemistry, Jul-19, Volume: 44, Issue:15
Volume learning algorithm artificial neural networks for 3D QSAR studies.
AID49676Displacement of [3H]CP-55940 from Cannabinoid receptor 1 of rat forebrain membranes1998Journal of medicinal chemistry, Nov-05, Volume: 41, Issue:23
Three-dimensional quantitative structure-activity relationship study of the cannabimimetic (aminoalkyl)indoles using comparative molecular field analysis.
AID254378Binding affinity towards rat forebrain cannabinoid receptor 1 using [3H]CP-559402005Journal of medicinal chemistry, Oct-06, Volume: 48, Issue:20
Potent cannabinergic indole analogues as radioiodinatable brain imaging agents for the CB1 cannabinoid receptor.
AID49677Cannabinoid receptor 1 binding affinity by measuring its ability to displace [3H]WIN-55212-2 in rat forebrain membranes1998Journal of medicinal chemistry, Nov-05, Volume: 41, Issue:23
Three-dimensional quantitative structure-activity relationship study of the cannabimimetic (aminoalkyl)indoles using comparative molecular field analysis.
AID254377Binding affinity towards mouse spleen cannabinoid receptor 2 using [3H]CP-559402005Journal of medicinal chemistry, Oct-06, Volume: 48, Issue:20
Potent cannabinergic indole analogues as radioiodinatable brain imaging agents for the CB1 cannabinoid receptor.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (14.29)18.2507
2000's3 (42.86)29.6817
2010's3 (42.86)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.72

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.72 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.80 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.72)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]